Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin Y-like protein 2 (pseudogene) (CCNYL2)
- Target
- CCNYL2
- Molecular classification
- Other, Pseudogene
01
Overview
Cyclin Y-like protein 2 (CCNYL2) is annotated as a pseudogene and is predicted to enable protein kinase binding activity and potentially participate in the regulation of canonical Wnt signaling pathways[4][2]. Currently, there is no confirmed evidence that CCNYL2 encodes a functional protein in humans, nor is there evidence supporting its role as a therapeutic target, disease biomarker, or drug interaction partner. The gene is part of the cyclins (CCN) family, but is generally classified as a pseudogene with limited functional characterization and uncertain biological roles[4][2].
- Other names
- C10orf21CCNYL2PbA178A10.2Cyclin-Y-like protein 2
02
Biological functions
Predicted protein kinase bindingregulation of canonical Wnt signaling pathway (predicted)
Beyond the preview
Go deeper on Cyclin Y-like protein 2 (pseudogene) (CCNYL2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyclin Y-like protein 2 (pseudogene) (CCNYL2).